Časopis České psychiatrické společnosti ČLS JEP a Psychiatrickej spoločnosti SLS. The most frequently used antipsychotics, either alone or in combinations, were clozapine and olanzapine.
Vincent and Kouassi are responding in The Lancet to Stefan Leucht, who conducted a meta-analysis of over 200 articles on the efficacy and side effects of 15 antipsychotics. . Anti-obesity drug
In October 2005, one month after CATIE was published, the Journal of the American Medical Association published a meta-analysis of 15 randomized trials of more than 5,000 elderly patients treated with atypical antipsychotics.
Chakos M, Lieberman J, Hoffman E, Bradford D, Sheitman B. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am J Psychiatry (2001.
tions of LAI-A in the Czech Republic represent 6% of all antipsychotics. There are estimations that 10% of patients with schizophrenia. Indikace DPIA se od obecné indikace anti-. Depot risperidone for schizophrenia (Review).
Research from JAMA Psychiatry — National Trends in the Office-Based Treatment of Children, Adolescents, and Adults With Antipsychotics. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis.
have heart disease, one in ﬁve has diabetes mellitus, half. screening for breast and colorectal cancer: Meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark.
Efficacy and Comparative Effectiveness of Atypical Antipsychotic Medications for Off-Label Uses in Adults: A Systematic Review and Meta-Analysis
Anti-Psychotics is closed. 9. Maher, AR, Maglione, M, Bagley, S, Suttorp, M, et al., Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis.
Times-series analyses of the reimbursable anxiolytics, sedative/hypnotics, and antipsychotics showed some evidence of potential substitution for benzodiazepines in the no-coverage state after implementation of Medicare Part D (Figure 1).